We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$3.84B
AUM Growth
+$272M
Cap. Flow
+$189M
Cap. Flow %
4.93%
Top 10 Hldgs %
20.07%
Holding
671
New
230
Increased
99
Reduced
90
Closed
234

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$103M
2
MMM icon
3M
MMM
+$64.5M
3
SNN icon
Smith & Nephew
SNN
+$51.4M
4
MOD icon
Modine Manufacturing
MOD
+$47.9M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$40.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.46%
2 Industrials 14.61%
3 Technology 10.28%
4 Healthcare 8.88%
5 Communication Services 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
376
Heron Therapeutics
HRTX
$93.9M
$413K 0.01%
+270,100
New +$438K
EHTH icon
377
eHealth
EHTH
$42.2M
$411K 0.01%
+43,705
New +$243K
RNAM
378
CALL
DELISTED
Avidity Biosciences
RNAM
$395K 0.01%
+13,600
New +$568K
TARS icon
379
CALL
Tarsus Pharmaceuticals
TARS
$2.58B
$393K 0.01%
7,100
-87,400
-92% -$3.97M
VRDN icon
380
CALL
Viridian Therapeutics
VRDN
$2.09B
$393K 0.01%
+20,500
New +$446K
PYPD icon
381
PolyPid
PYPD
$82.3M
$391K 0.01%
+128,483
New +$422K
WGMI icon
382
CoinShares ETF Trust CoinShares Bitcoin Mining ETF
WGMI
$276M
$388K 0.01%
+17,500
New +$424K
LESL icon
383
Leslie's
LESL
$8.9M
$377K 0.01%
8,450
-58,593
-87% -$3.11M
HPP
384
Hudson Pacific Properties
HPP
$747M
$366K 0.01%
+17,250
New +$471K
PETS icon
385
PetMed Express
PETS
$41.7M
$347K 0.01%
+72,000
New +$337K
DAWN
386
PUT
DELISTED
Day One Biopharmaceuticals
DAWN
$342K 0.01%
27,000
MELI icon
387
Mercado Libre
MELI
$95.2B
$340K 0.01%
200
-40
-17% -$77.9K
FND icon
388
Floor & Decor
FND
$6.13B
$331K 0.01%
+3,318
New +$356K
GILD icon
389
Gilead Sciences
GILD
$162B
$312K 0.01%
3,373
-60,064
-95% -$5.41M
M icon
390
Macy's
M
$6.53B
$306K 0.01%
18,078
+3,258
+22% +$51.9K
MRUS
391
DELISTED
Merus
MRUS
$294K 0.01%
7,001
-33,499
-83% -$1.61M
NU icon
392
Nu Holdings
NU
$69.2B
$290K 0.01%
+28,004
New +$372K
SPRY icon
393
CALL
ARS Pharmaceuticals
SPRY
$509M
$286K 0.01%
27,100
+100
+0.4% +$1.4K
CPRX
394
DELISTED
Catalyst Pharmaceutical
CPRX
$282K 0.01%
13,500
MREO
395
Mereo BioPharma
MREO
$54.7M
$278K 0.01%
79,387
-175,503
-69% -$690K
TGT icon
396
Target
TGT
$65.6B
$269K 0.01%
1,990
-32,378
-94% -$4.64M
HNRG icon
397
Hallador Energy
HNRG
$670M
$257K 0.01%
22,414
-93,819
-81% -$1.05M
TGTX icon
398
TG Therapeutics
TGTX
$7.96B
$242K 0.01%
8,036
-34,751
-81% -$997K
VSXY
399
Victoria's Secret
VSXY
$7.05B
$241K 0.01%
5,810
-187,506
-97% -$6.62M
RDFN
400
CALL
DELISTED
Redfin
RDFN
$236K 0.01%
30,000
-60,000
-67% -$582K

Similar funds

J. Goldman & Co's Q4 2024 Portfolio in Review

As of Q4 2024, J. Goldman & Co held 671 positions worth $3.84B, up 7.6% from $3.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

J. Goldman & Co deployed $189M of net new capital in Q4 2024, opening 230 new positions and adding to 99 existing holdings. Its largest new stake was 3M: 491,679 shares worth $63.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $67.4M trimmed.

  • J. Goldman & Co's largest Q4 2024 buy was 3M: 491,679 shares worth $63.5M.
  • J. Goldman & Co added most to Walt Disney in Q4 2024, an estimated $103M increase.
  • J. Goldman & Co's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $67.4M.
  • J. Goldman & Co fully exited Comcast in Q4 2024, selling an estimated $79.7M.
  • J. Goldman & Co's ten largest holdings make up 20% of its $3.84B portfolio in Q4 2024.
  • J. Goldman & Co opened 230 new positions and closed 234 in Q4 2024.
  • J. Goldman & Co's portfolio value rose 7.6% quarter-over-quarter to $3.84B.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.